Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man
- PMID: 5787671
- PMCID: PMC1703386
- DOI: 10.1111/j.1476-5381.1969.tb09511.x
Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man
Abstract
1. Preliminary studies in man of a new beta-adrenoceptive receptor blocking drug, DL-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB46), are described.2. LB46, 0.5 mg by oral administration, appeared to be of similar potency to propranolol 20 mg in inhibiting isoprenaline-induced and exercise-induced tachycardia.3. In comparable beta-receptor blocking doses LB46 did not show the negative chronotropic property possessed by propranolol.
References
-
- Br J Pharmacol Chemother. 1968 Mar;32(3):663-70 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
